These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9639745

  • 21. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF, Ren FR, Guo SP.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [Abstract] [Full Text] [Related]

  • 22. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 23. [Hyperprolactinemia and disorders of the menstrual cycle].
    Topalski-Fistes N, Bujas M, Maticki-Sekulić M, Suvacarev S.
    Med Pregl; 1999 Jan; 52(3-5):156-61. PubMed ID: 10518402
    [Abstract] [Full Text] [Related]

  • 24. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
    Guido M, Romualdi D, De Marinis L, Porcelli T, Giuliani M, Costantini B, Lanzone A.
    Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
    [Abstract] [Full Text] [Related]

  • 25. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hyperprolactinemia and polycystic ovarian syndrome.
    Tzingounis VA, Aksu MF, Tsoukalos SG.
    Int J Fertil; 1979 Feb; 24(4):276-80. PubMed ID: 45100
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 33. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR, Sowter MC, Carter MA, Knox BS, Gunn AJ.
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [Abstract] [Full Text] [Related]

  • 34. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.
    Waśko R, Komarowska H, Warenik-Szymankiewicz A, Sowiński J.
    Horm Metab Res; 2004 Mar; 36(3):170-3. PubMed ID: 15057670
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.